HealthDay News — COVID-19 is associated with long-term risk for autoimmune and autoinflammatory connective tissue disorders, according to a study published online Nov. 6 in JAMA Dermatology.
Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.
A health literacy-informed digital intervention reduces the incidence of obesity at 24 months of age. HealthDay News — A health literacy-informed digital intervention reduces the incidence of obesity ...
Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.
Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could avert 42,000 deaths annually ...
No significant relationship was identified between body weight and the persistence of either intravenous or subcutaneous tocilizumab among patients with rheumatoid arthritis. Body weight may influence ...
Elevated baseline resting heart rate (RHR) is associated with an increased risk for incident atrial fibrillation (AF) in Black adults. HealthDay News — Elevated baseline resting heart rate (RHR) is ...
When was the first National Diabetes Month and how has diabetes research evolved over the years? November is National Diabetes Month, dedicated to increasing awareness and education on how diabetes ...
The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of ...
Patients with hyperglycemic crisis at type 2 diabetes diagnosis should be closely monitored for acute kidney injury and chronic kidney disease. The risk for chronic kidney disease (CKD) is higher for ...
Among patients with rheumatoid arthritis, JAK inhibitors were slightly more effective for reducing pain at 3 and 12 months when compared with TNF inhibitors.
Rheumatology Advisor interviewed Fiona Watt, PhD, to discuss the relationship between menopause and rheumatic disease.